Beijing: A Chinese pharmaceutical company on Thursday said the coronavirus vaccine it is developing should be ready by early 2021 for distribution worldwide, including the United States.
Yin Weidong, the CEO of SinoVac, vowed to apply to the US Food and Drug Administration to sell CoronaVac in the United States if it passes its third and final round of testing in humans. Yin said he personally has been given the experimental vaccine.
At the very beginning, our strategy was designed for China and for Wuhan. Soon after that in June and July we adjusted our strategy, that is to face the world, Yin said, referring to the Chinese city were the virus first emerged.
Our goal is to provide the vaccine to the world including the US, EU and others, Yin said. Stringent regulations in the US, European Union, Japan and Australia have historically blocked the sale of Chinese vaccines. But Yin said that could change. SinoVac is developing one of China’s top four vaccine candidates along with state-owned SinoPharm, which has two in development, and military-affiliated private firm CanSino.
More than 24,000 people are currently participating in clinical trials of CoronaVac in Brazil, Turkey, and Indonesia, with additional trials scheduled for Bangladesh and possibly Chile, Yin said. (AP)
